Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

New drug targets for acute myeloid leukemia identified through a comprehensive analysis of the plasma protein

Submitted by Anna Hakala on Tue, 02/03/2026 - 10:43
  • Read more about New drug targets for acute myeloid leukemia identified through a comprehensive analysis of the plasma protein

Exploring the pathogenic mechanism of RNH1 in colorectal cancer based on eQTL, Multi-omics and deep learning

Submitted by Anna Hakala on Tue, 02/03/2026 - 10:42
  • Read more about Exploring the pathogenic mechanism of RNH1 in colorectal cancer based on eQTL, Multi-omics and deep learning

Decoding the shared genetic architecture of hidradenitis suppurativa with cardiovascular diseases and metabolic traits

Submitted by Anna Hakala on Tue, 02/03/2026 - 10:41
  • Read more about Decoding the shared genetic architecture of hidradenitis suppurativa with cardiovascular diseases and metabolic traits

Multi-omics reveals that genes linked to succinylation regulate the onset of epilepsy through metabolic reprogramming

Submitted by Anna Hakala on Tue, 02/03/2026 - 10:40
  • Read more about Multi-omics reveals that genes linked to succinylation regulate the onset of epilepsy through metabolic reprogramming

Integrative multi-omics analysis of druggable genes for therapeutic target identification in polycystic ovary syndrome

Submitted by Anna Hakala on Tue, 02/03/2026 - 10:38
  • Read more about Integrative multi-omics analysis of druggable genes for therapeutic target identification in polycystic ovary syndrome

Uncovering the mediating role of CSF metabolites in the gut microbiota–glioblastoma axis via causal mediation analysis

Submitted by Anna Hakala on Tue, 02/03/2026 - 10:37
  • Read more about Uncovering the mediating role of CSF metabolites in the gut microbiota–glioblastoma axis via causal mediation analysis

Mapping the disease continuum of anxiety disorder

Submitted by Anna Hakala on Tue, 02/03/2026 - 10:32
  • Read more about Mapping the disease continuum of anxiety disorder

Comprehensive genomic insights into the genetic causality and comorbidity in urological cancers

Submitted by Anna Hakala on Tue, 02/03/2026 - 10:30
  • Read more about Comprehensive genomic insights into the genetic causality and comorbidity in urological cancers

Mendelian randomization and bioinformatics analysis identify the association between plasma proteins and cataract

Submitted by Anna Hakala on Tue, 02/03/2026 - 10:27
  • Read more about Mendelian randomization and bioinformatics analysis identify the association between plasma proteins and cataract

Interaction between sleep disorder and depression on early onset hypertension: a machine learning modelling approach

Submitted by Anna Hakala on Tue, 02/03/2026 - 10:25
  • Read more about Interaction between sleep disorder and depression on early onset hypertension: a machine learning modelling approach

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Current page 15
  • Page 16
  • Page 17
  • Page 18
  • Page 19
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement